Dr. Reddy's Laboratories Limited(NYSE:RDY) 
Dr. Reddy's Laboratories Limited operates as an integrated pharmaceutical company worldwide. It operates through three segments: Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), and Proprietary Products. Dr. Reddy's Laboratories Limited operates as an integrated pharmaceutical...
Website: http://www.drreddys.com
Founded: 1984
Full Time Employees: 21,650
CEO: Erez Israeli
Sector: Healthcare
Industry: Drug Manufacturers-Specialty & Generic
• Market Cap:
• Exchange:
• Shs Outstanding:
• Employees:
• Beta:
• Return on Equity (ROE) ttm:
• Return on Assets (ROA) ttm:
• EPS ttm:
• Book value per Share:
• Cash per Share:
• Current ast per Share:
• P/E ttm:
• P/E forward:
• P/E ttm high:
• P/E ttm low:
• P/S ttm:
• P/B ttm:
• P/FCF ttm:
• PEG ratio:
• Cash Ratio ttm:
• Quick Ratio ttm:
• Current Ratio ttm:
• Gross Mgn ttm:
• EBITDA Mgn ttm:
• Operating Mgn ttm:
• Net Income Mgn ttm:
• Trailing Div yield:
• Forward Div yield:
• Payout Ratio ttm:
• Ex-Dividend date:
• Target Price High:
• Target Price Low:
• Target Price Mean:
• Number of Analysts:
• Debt Ratio ttm:
• Debt to Equity ttm:
• Total Net Debt:
At a glance:
Bull Thesis:
Bear Thesis:
Main Competitors:
Moat:
Income Statements:
Quarterly
Annual
| Unit: USD | 2024-01-30 | 2023-01-26 | 2023-01-25 | 2022-10-29 | 2022-10-28 | 2022-09-30 | 2022-07-29 | 2022-07-28 | 2022-06-30 | 2022-05-19 | 2022-03-31 | 2022-01-28 | 2021-12-31 | 2021-11-06 | 2021-11-05 | 2021-10-29 | 2021-07-27 | 2021-05-14 | 2021-03-31 | 2021-02-02 | 2021-01-29 | 2020-10-28 | 2020-07-29 | 2020-05-20 | 2020-03-31 | 2020-01-27 | 2019-11-01 | 2019-07-29 | 2019-05-17 | 2019-03-31 | 2019-02-01 | 2018-10-26 | 2018-07-26 | 2018-05-22 | 2018-03-31 | 2018-01-25 | 2017-10-31 | 2017-07-28 | 2017-05-15 | 2017-03-31 | 2017-02-07 | 2016-10-25 | 2016-07-27 | 2016-05-13 | 2016-03-31 | 2016-02-10 | 2015-10-30 | 2015-07-31 | 2015-05-13 | 2015-03-31 | 2014-03-31 | 2013-03-31 | 2012-03-31 | 2011-03-31 | 2010-03-31 | 2009-03-31 | 2008-03-31 | 2007-03-31 | 2006-03-31 | 2005-03-31 | 2004-03-31 | 2003-03-31 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
weighted-average tax rate | 23.7 | 23.7 | 30.9 | 30.9 | 18.96 | 18.96 | 27.1 | 21.8 | 21.8 | 23.12 | 93.04 | |||||||||||||||||||||||||||||||||||||||||||||||||||
tax expense | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
tax expense recognized directly in the equity | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
depreciation | 2,022 | 2,022 | 2,022 | 2,022 | 2,021 | 2,021 | 2,021 | 505 | 2,020 | |||||||||||||||||||||||||||||||||||||||||||||||||||||
cost of revenues | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
selling, general and administrative expenses | 401 | 401 | 376 | 376 | 371 | 371 | 377 | 384 | 384 | 369 | 746,998,882 | 378 | ||||||||||||||||||||||||||||||||||||||||||||||||||
research and development expenses | 251 | 251 | 231 | 231 | 246 | 246 | 273 | 260 | 260 | 253 | 225,999,275 | 243 | ||||||||||||||||||||||||||||||||||||||||||||||||||
tax expense recognised directly in the equity |
Balance Sheets:
Quarterly
Annual
| Unit: USD | 2025-10-24 | 2025-07-23 | 2025-01-23 | 2024-11-05 | 2024-07-27 | 2024-01-30 | 2023-10-27 | 2023-07-28 | 2023-07-26 | 2023-01-26 | 2023-01-25 | 2022-10-29 | 2022-09-30 | 2022-07-29 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-11-06 | 2021-11-05 | 2021-07-27 | 2021-02-02 | 2020-10-29 | 2020-07-29 | 2020-03-31 | 2020-01-31 | 2019-11-01 | 2019-07-29 | 2019-03-31 | 2018-12-31 | 2018-09-30 | 2018-06-30 | 2018-03-31 | 2017-12-31 | 2017-09-30 | 2017-06-30 | 2017-03-31 | 2016-12-31 | 2016-09-30 | 2016-06-30 | 2016-03-31 | 2015-12-31 | 2015-09-30 | 2015-06-30 | 2015-03-31 | 2014-12-31 | 2014-09-30 | 2014-06-30 | 2014-03-31 | 2013-12-31 | 2013-09-30 | 2013-06-30 | 2013-03-31 | 2012-12-31 | 2012-09-30 | 2012-06-30 | 2012-03-31 | 2011-09-30 | 2011-06-30 | 2011-03-31 | 2010-12-31 | 2010-09-30 | 2010-06-30 | 2010-03-31 | 2003-03-31 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
assets | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
current assets | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
cash and cash equivalents | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
other investments | 675,000,000 | 673,000,000 | 548,000,000 | 618,000,000 | 1,077,000,000 | 782,000,000 | 655,000,000 | 646,000,000 | 646,000,000 | 511,000,000 | 511,000,000 | 227,000,000 | 227,000,000 | 358,000,000 | 358,000,000 | 389,000,000 | 178,000,000 | 197,000,000 | 197,000,000 | 274,000,000 | 158,000,000 | 288,000,000 | 308,000,000 | 314,000,000 | 245,000,000 | 362,000,000 | 357,000,000 | 326,000,000 | 331,000,000 | 215,000,000 | 196,000,000 | 282,000,000 | 313,000,000 | 219,000,000 | 182,000,000 | 220,000,000 | 208,000,000 | 284,000,000 | 285,000,000 | 529,000,000 | 485,000,000 | 418,000,000 | 453,000,000 | 550,000,000 | 356,000,000 | 331,000,000 | 440,000,000 | 418,000,000 | 161,000,000 | 251,000,000 | 350,000,000 | 311,000,000 | 264,000,000 | 258,000,000 | 232,000,000 | 212,000,000 | 37,000,000 | 2,000,000 | 1,000,000 | 7,000,000 | 1,000,000 | 51,000,000 | 80,000,000 | |
trade and other receivables | 1,101,000,000 | 1,110,000,000 | 1,078,000,000 | 1,008,000,000 | 973,000,000 | 943,000,000 | 839,000,000 | 939,000,000 | 939,000,000 | 907,000,000 | 907,000,000 | 946,000,000 | 946,000,000 | 927,000,000 | 927,000,000 | 880,000,000 | 839,000,000 | 925,000,000 | 925,000,000 | 821,000,000 | 728,000,000 | 681,000,000 | 617,000,000 | 667,000,000 | 622,000,000 | 576,000,000 | 549,000,000 | 576,000,000 | 535,000,000 | 636,000,000 | 700,000,000 | 624,000,000 | 665,000,000 | 646,000,000 | 637,000,000 | 587,000,000 | 605,000,000 | 555,000,000 | 526,000,000 | 623,000,000 | 633,000,000 | 654,000,000 | 661,000,000 | 654,000,000 | 638,000,000 | 609,000,000 | 601,000,000 | 551,000,000 | ||||||||||||||||
inventories | 854,000,000 | 882,000,000 | 837,000,000 | 860,000,000 | 823,000,000 | 731,000,000 | 681,000,000 | 639,000,000 | 639,000,000 | 596,000,000 | 596,000,000 | 603,000,000 | 603,000,000 | 656,000,000 | 656,000,000 | 671,000,000 | 668,000,000 | 670,000,000 | 670,000,000 | 683,000,000 | 607,000,000 | 559,000,000 | 518,000,000 | 465,000,000 | 529,000,000 | 496,000,000 | 510,000,000 | 486,000,000 | 487,000,000 | 448,000,000 | 460,000,000 | 447,000,000 | 420,000,000 | 413,000,000 | 435,000,000 | 440,000,000 | 442,000,000 | 428,000,000 | 414,000,000 | 386,000,000 | 403,000,000 | 414,000,000 | 411,000,000 | 410,000,000 | 461,000,000 | 454,000,000 | 422,000,000 | 400,000,000 | 390,000,000 | 381,000,000 | 379,000,000 | 396,000,000 | 422,000,000 | 414,000,000 | 370,000,000 | 380,000,000 | 379,000,000 | 390,000,000 | 361,000,000 | 340,000,000 | 331,000,000 | 311,000,000 | 297,000,000 | 2,781,384,000 |
derivative financial instruments | 1,000,000 | 8,000,000 | 6,000,000 | 5,000,000 | 5,000,000 | 4,000,000 | 9,000,000 | 22,000,000 | 22,000,000 | 2,000,000 | 2,000,000 | 7,000,000 | 7,000,000 | 1,000,000 | 1,000,000 | 25,000,000 | 24,000,000 | 16,000,000 | 16,000,000 | 10,000,000 | 26,000,000 | 13,000,000 | 5,000,000 | 15,000,000 | 10,000,000 | 6,000,000 | 5,000,000 | 5,000,000 | 9,000,000 | 5,000,000 | 4,000,000 | 2,000,000 | 6,000,000 | 3,000,000 | 5,000,000 | 4,000,000 | 1,000,000 | 2,000,000 | 1,000,000 | 3,000,000 | 3,000,000 | 3,000,000 | 9,000,000 | 13,000,000 | 18,000,000 | 7,000,000 | 6,000,000 | 9,000,000 | 3,000,000 | 7,000,000 | 2,000,000 | 10,000,000 | 4,000,000 | 20,000,000 | 49,000,000 | 36,000,000 | 18,000,000 | 18,000,000 | 15,000,000 | 14,000,000 | 13,000,000 | |||
other current assets | 406,000,000 | 371,000,000 | 336,000,000 | 337,000,000 | 294,000,000 | 283,000,000 | 270,000,000 | 226,000,000 | 226,000,000 | 231,000,000 | 231,000,000 | 225,000,000 | 225,000,000 | 205,000,000 | 205,000,000 | 183,000,000 | 188,000,000 | 214,000,000 | 214,000,000 | 202,000,000 | 220,000,000 | 212,000,000 | 419,000,000 | 183,000,000 | 163,000,000 | 176,000,000 | 189,000,000 | 181,000,000 | 185,000,000 | 181,000,000 | 218,000,000 | 220,000,000 | 217,000,000 | 201,000,000 | 191,000,000 | 185,000,000 | 172,000,000 | 172,000,000 | 173,000,000 | 166,000,000 | 167,000,000 | 180,000,000 | 180,000,000 | 181,000,000 | 185,000,000 | 191,000,000 | 180,000,000 | 189,000,000 | 180,000,000 | 181,000,000 | 157,000,000 | 165,000,000 | 166,000,000 | 161,000,000 | 132,000,000 | 128,000,000 | 156,000,000 | 160,000,000 | 156,000,000 | 140,000,000 | 152,000,000 | 129,000,000 | 121,000,000 | 1,235,999,000 |
total current assets | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
non-current assets | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
property, plant and equipment | 685,000,000 | 666,000,000 | 605,000,000 | 570,000,000 | 516,000,000 | 500,000,000 | 4,830,480,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
goodwill | 139,000,000 | 140,000,000 | 139,000,000 | 141,000,000 | 51,000,000 | 52,000,000 | 51,000,000 | 52,000,000 | 52,000,000 | 54,000,000 | 54,000,000 | 53,000,000 | 53,000,000 | 55,000,000 | 55,000,000 | 58,000,000 | 61,000,000 | 62,000,000 | 62,000,000 | 62,000,000 | 63,000,000 | 62,000,000 | 64,000,000 | 53,000,000 | 55,000,000 | 55,000,000 | 57,000,000 | 56,000,000 | 57,000,000 | 55,000,000 | 57,000,000 | 61,000,000 | 61,000,000 | 59,000,000 | 59,000,000 | 58,000,000 | 56,000,000 | 58,000,000 | 57,000,000 | 58,000,000 | 57,000,000 | 58,000,000 | 59,000,000 | 54,000,000 | 56,000,000 | 57,000,000 | 57,000,000 | 57,000,000 | 56,000,000 | 55,000,000 | 56,000,000 | 59,000,000 | 37,000,000 | 39,000,000 | 40,000,000 | 43,000,000 | 45,000,000 | 49,000,000 | 49,000,000 | 48,000,000 | 49,000,000 | 47,000,000 | 48,000,000 | |
other intangible assets | 1,137,000,000 | 1,115,000,000 | 1,086,000,000 | 1,100,000,000 | 446,000,000 | 444,000,000 | 446,000,000 | 464,000,000 | 464,000,000 | 374,000,000 | 374,000,000 | 390,000,000 | 390,000,000 | 403,000,000 | 403,000,000 | 359,000,000 | 431,000,000 | 440,000,000 | 440,000,000 | 473,000,000 | 499,000,000 | 557,000,000 | 545,000,000 | 367,000,000 | 377,000,000 | 573,000,000 | 637,000,000 | 642,000,000 | 651,000,000 | 652,000,000 | 662,000,000 | 686,000,000 | 694,000,000 | 701,000,000 | 692,000,000 | 693,000,000 | 680,000,000 | 705,000,000 | 362,000,000 | 314,000,000 | 316,000,000 | 311,000,000 | 320,000,000 | 209,000,000 | 227,000,000 | 163,000,000 | 181,000,000 | 188,000,000 | 197,000,000 | 205,000,000 | 222,000,000 | 263,000,000 | 286,000,000 | 293,000,000 | 242,000,000 | 254,000,000 | 240,000,000 | 262,000,000 | ||||||
investment in equity accounted investees | 58,000,000 | 58,000,000 | 55,000,000 | 57,000,000 | 51,000,000 | 51,000,000 | 49,000,000 | 49,000,000 | 49,000,000 | 56,000,000 | 56,000,000 | 54,000,000 | 54,000,000 | 55,000,000 | 55,000,000 | 57,000,000 | 56,000,000 | 52,000,000 | 52,000,000 | 49,000,000 | 44,000,000 | 40,000,000 | 38,000,000 | 37,000,000 | 36,000,000 | 33,000,000 | 32,000,000 | 37,000,000 | 34,000,000 | 32,000,000 | 32,000,000 | 32,000,000 | 30,000,000 | 28,000,000 | 27,000,000 | 25,000,000 | 23,000,000 | 22,000,000 | 21,000,000 | 20,000,000 | 19,000,000 | 18,000,000 | 17,000,000 | 17,000,000 | 16,000,000 | 15,000,000 | 14,000,000 | 13,000,000 | 9,000,000 | 8,000,000 | 8,000,000 | 7,000,000 | 7,000,000 | 7,000,000 | 7,000,000 | 7,000,000 | 7,000,000 | 7,000,000 | 7,000,000 | 7,000,000 | ||||
deferred tax assets | 256,000,000 | 282,000,000 | 214,000,000 | 209,000,000 | 179,000,000 | 131,000,000 | 130,000,000 | 116,000,000 | 116,000,000 | 76,000,000 | 76,000,000 | 93,000,000 | 93,000,000 | 116,000,000 | 116,000,000 | 108,000,000 | 116,000,000 | 127,000,000 | 127,000,000 | 142,000,000 | 162,000,000 | 172,000,000 | 161,000,000 | 162,000,000 | 158,000,000 | 140,000,000 | 67,000,000 | 60,000,000 | 71,000,000 | 77,000,000 | 71,000,000 | 56,000,000 | 61,000,000 | 82,000,000 | 87,000,000 | 86,000,000 | 90,000,000 | 89,000,000 | 87,000,000 | 75,000,000 | 83,000,000 | 101,000,000 | 95,000,000 | 93,000,000 | 82,000,000 | 112,000,000 | 111,000,000 | 101,000,000 | 86,000,000 | 78,000,000 | 64,000,000 | 67,000,000 | ||||||||||||
tax assets | 42,000,000 | 32,000,000 | 18,000,000 | 27,000,000 | 31,000,000 | 35,000,000 | 4,000,000 | 2,000,000 | 2,000,000 | 28,000,000 | 28,000,000 | 38,000,000 | 38,000,000 | 47,000,000 | 47,000,000 | 53,000,000 | 48,000,000 | 43,000,000 | 43,000,000 | 34,000,000 | 27,000,000 | 30,000,000 | 33,000,000 | 58,000,000 | 42,000,000 | 42,000,000 | 37,000,000 | 49,000,000 | 51,000,000 | 45,000,000 | 55,000,000 | |||||||||||||||||||||||||||||||||
other non-current assets | 12,000,000 | 11,000,000 | 16,000,000 | 18,000,000 | 20,000,000 | 14,000,000 | 10,000,000 | 10,000,000 | 10,000,000 | 22,000,000 | 22,000,000 | 22,000,000 | 22,000,000 | 23,000,000 | 23,000,000 | 12,000,000 | 13,000,000 | 11,000,000 | 11,000,000 | 11,000,000 | 12,000,000 | 12,000,000 | 11,000,000 | 11,000,000 | 12,000,000 | 13,000,000 | 13,000,000 | 14,000,000 | 15,000,000 | 16,000,000 | 15,000,000 | 16,000,000 | 16,000,000 | 16,000,000 | 16,000,000 | 15,000,000 | 17,000,000 | 16,000,000 | 16,000,000 | 16,000,000 | 13,000,000 | 13,000,000 | 13,000,000 | 12,000,000 | 13,000,000 | 13,000,000 | 9,000,000 | 8,000,000 | 9,000,000 | 9,000,000 | 9,000,000 | 9,000,000 | 12,000,000 | 12,000,000 | 9,000,000 | 8,000,000 | 7,000,000 | 7,000,000 | 6,000,000 | 6,000,000 | 6,000,000 | 6,000,000 | 5,000,000 | |
total non-current assets | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
total assets | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
liabilities and equity | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
current liabilities | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
trade and other payables | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
short-term borrowings | 464,000,000 | 448,000,000 | 496,000,000 | 477,000,000 | 278,000,000 | 148,000,000 | 70,000,000 | 79,000,000 | 79,000,000 | 139,000,000 | 139,000,000 | 132,000,000 | 132,000,000 | 227,000,000 | 227,000,000 | 357,000,000 | 287,000,000 | 315,000,000 | 315,000,000 | 354,000,000 | 180,000,000 | 270,000,000 | 293,000,000 | 218,000,000 | 128,000,000 | 146,000,000 | 198,000,000 | 175,000,000 | 248,000,000 | 384,000,000 | 410,000,000 | 391,000,000 | 475,000,000 | 438,000,000 | 399,000,000 | 671,000,000 | 768,000,000 | 744,000,000 | 395,000,000 | 343,000,000 | 348,000,000 | 402,000,000 | 349,000,000 | 351,000,000 | 257,000,000 | 227,000,000 | 292,000,000 | 343,000,000 | 314,000,000 | 303,000,000 | 419,000,000 | 347,000,000 | 355,000,000 | 341,000,000 | 324,000,000 | 311,000,000 | 525,000,000 | 418,000,000 | 409,000,000 | 303,000,000 | 161,000,000 | 131,000,000 | 124,000,000 | |
long-term borrowings, current portion | 65,000,000 | 60,000,000 | 13,000,000 | 14,000,000 | 15,000,000 | 16,000,000 | 16,000,000 | 14,000,000 | 14,000,000 | 57,000,000 | 57,000,000 | 58,000,000 | 58,000,000 | 62,000,000 | 62,000,000 | 13,000,000 | 11,000,000 | 12,000,000 | 12,000,000 | 12,000,000 | 11,000,000 | 11,000,000 | 35,000,000 | 57,000,000 | 84,000,000 | 84,000,000 | 60,000,000 | 62,000,000 | 27,000,000 | 1,000,000 | 1,000,000 | 1,000,000 | 1,000,000 | 1,000,000 | 2,000,000 | 2,000,000 | 2,000,000 | 2,000,000 | 2,000,000 | 2,000,000 | 1,000,000 | 112,000,000 | 112,000,000 | 112,000,000 | 112,000,000 | 85,000,000 | 57,000,000 | 110,000,000 | 82,000,000 | 86,000,000 | 94,000,000 | 1,000,000 | 1,000,000 | 1,000,000 | 1,000,000 | 1,000,000 | 1,000,000 | 111,000,000 | 76,000,000 | 82,000,000 | ||||
provisions | 74,000,000 | 77,000,000 | 65,000,000 | 61,000,000 | 66,000,000 | 64,000,000 | 63,000,000 | 66,000,000 | 66,000,000 | 59,000,000 | 59,000,000 | 58,000,000 | 58,000,000 | 57,000,000 | 57,000,000 | 56,000,000 | 54,000,000 | 50,000,000 | 50,000,000 | 47,000,000 | 52,000,000 | 53,000,000 | 52,000,000 | 50,000,000 | 59,000,000 | 61,000,000 | 60,000,000 | 60,000,000 | 56,000,000 | 54,000,000 | 53,000,000 | 57,000,000 | 61,000,000 | 59,000,000 | 67,000,000 | 70,000,000 | 73,000,000 | 69,000,000 | 65,000,000 | 72,000,000 | 67,000,000 | 68,000,000 | 68,000,000 | 68,000,000 | 54,000,000 | 51,000,000 | 48,000,000 | 47,000,000 | 42,000,000 | 41,000,000 | 42,000,000 | 42,000,000 | 40,000,000 | 37,000,000 | 40,000,000 | 38,000,000 | 30,000,000 | 31,000,000 | 29,000,000 | 29,000,000 | 27,000,000 | 25,000,000 | 24,000,000 | |
tax liabilities | 86,000,000 | 123,000,000 | 35,000,000 | 61,000,000 | 58,000,000 | 50,000,000 | 48,000,000 | 54,000,000 | 54,000,000 | 16,000,000 | 16,000,000 | 15,000,000 | 15,000,000 | 23,000,000 | 23,000,000 | 21,000,000 | 21,000,000 | 18,000,000 | 18,000,000 | 18,000,000 | 21,000,000 | 16,000,000 | 12,000,000 | 8,000,000 | 7,000,000 | 6,000,000 | 7,000,000 | 3,000,000 | 12,000,000 | 15,000,000 | 13,000,000 | |||||||||||||||||||||||||||||||||
other current liabilities | 527,000,000 | 511,000,000 | 491,000,000 | 499,000,000 | 438,000,000 | 468,000,000 | 442,000,000 | 434,000,000 | 434,000,000 | 420,000,000 | 420,000,000 | 409,000,000 | 409,000,000 | 418,000,000 | 418,000,000 | 448,000,000 | 421,000,000 | 412,000,000 | 412,000,000 | 409,000,000 | 419,000,000 | 399,000,000 | 404,000,000 | 390,000,000 | 373,000,000 | 347,000,000 | 344,000,000 | 352,000,000 | 326,000,000 | 325,000,000 | 327,000,000 | 348,000,000 | 356,000,000 | 333,000,000 | 317,000,000 | 337,000,000 | 331,000,000 | 310,000,000 | 312,000,000 | 333,000,000 | 312,000,000 | 283,000,000 | 263,000,000 | 278,000,000 | 262,000,000 | 252,000,000 | 252,000,000 | 254,000,000 | 246,000,000 | 223,000,000 | 244,000,000 | 262,000,000 | 274,000,000 | 284,000,000 | 264,000,000 | 268,000,000 | 241,000,000 | 230,000,000 | 262,000,000 | 206,000,000 | 180,000,000 | 169,000,000 | 175,000,000 | |
total current liabilities | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
non-current liabilities | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
long-term borrowings | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
deferred tax liabilities | 167,000,000 | 169,000,000 | 162,000,000 | 165,000,000 | 57,000,000 | 12,000,000 | 1,000,000 | 8,000,000 | 8,000,000 | 2,000,000 | 2,000,000 | 1,000,000 | 1,000,000 | 1,000,000 | 1,000,000 | 1,000,000 | 1,000,000 | 1,000,000 | 1,000,000 | 1,000,000 | 1,000,000 | 3,000,000 | 3,000,000 | 4,000,000 | 4,000,000 | 5,000,000 | 8,000,000 | 9,000,000 | 9,000,000 | 10,000,000 | 10,000,000 | 11,000,000 | 12,000,000 | 13,000,000 | 13,000,000 | 19,000,000 | 21,000,000 | 18,000,000 | 11,000,000 | 12,000,000 | 28,000,000 | 29,000,000 | 32,000,000 | 29,000,000 | 40,000,000 | 46,000,000 | 48,000,000 | 46,000,000 | 36,000,000 | 29,000,000 | 24,000,000 | 36,000,000 | 34,000,000 | 37,000,000 | 19,000,000 | 22,000,000 | 42,000,000 | 48,000,000 | 45,000,000 | 47,000,000 | 52,000,000 | 49,000,000 | 61,000,000 | |
other non-current liabilities | 27,000,000 | 41,000,000 | 69,000,000 | 72,000,000 | 47,000,000 | 50,000,000 | 43,000,000 | 41,000,000 | 41,000,000 | 36,000,000 | 36,000,000 | 35,000,000 | 35,000,000 | 35,000,000 | 35,000,000 | 32,000,000 | 35,000,000 | 34,000,000 | 34,000,000 | 31,000,000 | 33,000,000 | 35,000,000 | 34,000,000 | 37,000,000 | 41,000,000 | 45,000,000 | 38,000,000 | 41,000,000 | 44,000,000 | 43,000,000 | 49,000,000 | 55,000,000 | 60,000,000 | 62,000,000 | 62,000,000 | 63,000,000 | 54,000,000 | 57,000,000 | 37,000,000 | 48,000,000 | 50,000,000 | 45,000,000 | 55,000,000 | 53,000,000 | 29,000,000 | 29,000,000 | 29,000,000 | 30,000,000 | 18,000,000 | 17,000,000 | 18,000,000 | 18,000,000 | ||||||||||||
total non-current liabilities | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
total liabilities | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
equity | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
share capital | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
treasury shares | -22,000,000 | -24,000,000 | -10,000,000 | -11,000,000 | -12,000,000 | -12,000,000 | -12,000,000 | -14,000,000 | -14,000,000 | -17,000,000 | -17,000,000 | -19,000,000 | -19,000,000 | -20,000,000 | -20,000,000 | -21,000,000 | -22,000,000 | -22,000,000 | -22,000,000 | -24,000,000 | -14,000,000 | -14,000,000 | -12,000,000 | -13,000,000 | -14,000,000 | -14,000,000 | -15,000,000 | -8,000,000 | -7,000,000 | -1,000,000 | ||||||||||||||||||||||||||||||||||
share premium | 127,000,000 | 131,000,000 | 130,000,000 | 132,000,000 | 130,000,000 | 129,000,000 | 128,000,000 | 120,000,000 | 120,000,000 | 116,000,000 | 116,000,000 | 116,000,000 | 116,000,000 | 118,000,000 | 118,000,000 | 122,000,000 | 124,000,000 | 124,000,000 | 124,000,000 | 122,000,000 | 122,000,000 | 120,000,000 | 115,000,000 | 113,000,000 | 119,000,000 | 119,000,000 | 121,000,000 | 119,000,000 | 118,000,000 | 112,000,000 | 116,000,000 | 120,000,000 | 121,000,000 | 118,000,000 | 116,000,000 | 113,000,000 | 108,000,000 | 110,000,000 | 102,000,000 | 341,000,000 | 341,000,000 | 345,000,000 | 354,000,000 | 356,000,000 | 352,000,000 | 358,000,000 | 365,000,000 | 359,000,000 | 348,000,000 | 344,000,000 | 361,000,000 | 389,000,000 | 381,000,000 | 411,000,000 | 426,000,000 | 468,000,000 | 464,000,000 | 463,000,000 | 444,000,000 | 454,000,000 | ||||
share-based payment reserve | 18,000,000 | 19,000,000 | 18,000,000 | 18,000,000 | 19,000,000 | 17,000,000 | 17,000,000 | 20,000,000 | 20,000,000 | 20,000,000 | 20,000,000 | 21,000,000 | 21,000,000 | 22,000,000 | 22,000,000 | 21,000,000 | 20,000,000 | 19,000,000 | 19,000,000 | 19,000,000 | 16,000,000 | 14,000,000 | 16,000,000 | |||||||||||||||||||||||||||||||||||||||||
capital redemption reserve | 2,000,000 | 2,000,000 | 2,000,000 | 2,000,000 | 2,000,000 | 2,000,000 | 2,000,000 | 2,000,000 | 2,000,000 | 2,000,000 | 2,000,000 | 2,000,000 | 2,000,000 | 2,000,000 | 2,000,000 | 2,000,000 | 2,000,000 | 2,000,000 | 2,000,000 | 2,000,000 | 2,000,000 | 2,000,000 | 2,000,000 | 2,000,000 | 2,000,000 | 2,000,000 | 3,000,000 | 2,000,000 | 2,000,000 | 2,000,000 | 3,000,000 | 3,000,000 | 3,000,000 | 3,000,000 | 3,000,000 | |||||||||||||||||||||||||||||
retained earnings | 3,804,000,000 | 3,849,000,000 | 3,499,000,000 | 3,405,000,000 | 3,351,000,000 | 3,030,000,000 | 2,867,000,000 | 2,803,000,000 | 2,803,000,000 | 2,499,000,000 | 2,499,000,000 | 2,386,000,000 | 2,386,000,000 | 2,377,000,000 | 2,377,000,000 | 2,316,000,000 | 2,351,000,000 | 2,263,000,000 | 2,263,000,000 | 2,176,000,000 | 2,084,000,000 | 2,073,000,000 | 1,986,000,000 | 1,913,000,000 | 1,914,000,000 | 2,014,000,000 | 1,963,000,000 | 1,860,000,000 | 1,786,000,000 | 1,647,000,000 | 1,730,000,000 | 1,749,000,000 | 1,737,000,000 | 1,646,000,000 | 1,681,000,000 | 1,669,000,000 | 1,547,000,000 | 1,508,000,000 | 1,494,000,000 | 1,503,000,000 | 1,493,000,000 | 1,420,000,000 | 1,414,000,000 | 1,342,000,000 | 1,245,000,000 | 1,174,000,000 | 1,175,000,000 | 1,084,000,000 | 935,000,000 | 830,000,000 | 810,000,000 | 822,000,000 | 625,000,000 | 621,000,000 | 478,000,000 | 511,000,000 | 458,000,000 | 455,000,000 | 434,000,000 | 401,000,000 | 8,322,811,000 | |||
other reserves | 45,000,000 | 46,000,000 | 47,000,000 | 48,000,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
other components of equity | 54,000,000 | 50,000,000 | 13,000,000 | 35,000,000 | 29,000,000 | 34,000,000 | 24,000,000 | 38,000,000 | 38,000,000 | 26,000,000 | 26,000,000 | 10,000,000 | 10,000,000 | 16,000,000 | 16,000,000 | 45,000,000 | 53,000,000 | 69,000,000 | 69,000,000 | 72,000,000 | 75,000,000 | 25,000,000 | 23,000,000 | 13,000,000 | 35,000,000 | 29,000,000 | 23,000,000 | 27,000,000 | 26,000,000 | 29,000,000 | 31,000,000 | 43,000,000 | 50,000,000 | 73,000,000 | 82,000,000 | 102,000,000 | 101,000,000 | 88,000,000 | 65,000,000 | 64,000,000 | 82,000,000 | 64,000,000 | 75,000,000 | 57,000,000 | 42,000,000 | 40,000,000 | 44,000,000 | 39,000,000 | 27,000,000 | 13,000,000 | 31,000,000 | 66,000,000 | 21,000,000 | 47,000,000 | 36,000,000 | 79,000,000 | 75,000,000 | 64,000,000 | 60,000,000 | 65,000,000 | ||||
equity attributable to equity holders of the parent company | 3,714,000,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
non-controlling interests | 40,000,000 | 43,000,000 | 45,000,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
total equity | 4,078,000,000 | 4,126,000,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
total liabilities and equity | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
special economic zone re-investment reserve | 6,000,000 | 6,000,000 | 7,000,000 | 9,000,000 | 10,000,000 | 11,000,000 | 11,000,000 | 3,000,000 | 3,000,000 | 4,000,000 | 4,000,000 | 7,000,000 | 7,000,000 | 10,000,000 | 13,000,000 | 14,000,000 | 14,000,000 | 17,000,000 | 21,000,000 | 14,000,000 | ||||||||||||||||||||||||||||||||||||||||||||
bank overdraft | 1,000,000 | 1,000,000 | 1,000,000 | 1,000,000 | 1,000,000 | 1,000,000 | 1,000,000 | 2,000,000 | 1,000,000 | 1,000,000 | 1,000,000 | 4,000,000 | 2,000,000 | 1,000,000 | 1,000,000 | |||||||||||||||||||||||||||||||||||||||||||||||||
debenture redemption reserve | 4,000,000 | 4,000,000 | 4,000,000 | 4,000,000 | 4,000,000 | 4,000,000 | 4,000,000 | 38,000,000 | 34,000,000 | 32,000,000 | 31,000,000 | 19,000,000 | 17,000,000 | 9,000,000 | 5,000,000 | |||||||||||||||||||||||||||||||||||||||||||||||||
total current assets before assets held for sale | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
assets held for sale | 2,000,000 | 2,000,000 | 2,000,000 | 2,000,000 | 2,000,000 | 14,000,000 | 10,000,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
share based payment reserve | 18,000,000 | 17,000,000 | 16,000,000 | 16,000,000 | 15,000,000 | 15,000,000 | 13,000,000 | 11,000,000 | 14,000,000 | 15,000,000 | 13,000,000 | 15,000,000 | 15,000,000 | 14,000,000 | 13,000,000 | 17,000,000 | 17,000,000 | 15,000,000 | 14,000,000 | 13,000,000 | 17,000,000 | 15,000,000 | 13,000,000 | 12,000,000 | 17,000,000 | 15,000,000 | 13,000,000 | 12,000,000 | 17,000,000 | 11,000,000 | 16,000,000 | 14,000,000 | 14,000,000 | 16,000,000 | 14,000,000 | 13,000,000 | 15,000,000 | |||||||||||||||||||||||||||
total current assets without disposal group | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
assets of disposal group held for sale | 11,000,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
total current liabilities without disposal group | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
liabilities of disposal group held for sale | 1,000,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
current tax assets | 70,000,000 | 63,000,000 | 57,000,000 | 54,000,000 | 53,000,000 | 24,000,000 | 27,000,000 | 19,000,000 | 25,000,000 | 22,000,000 | 3,000,000 | 9,000,000 | 29,000,000 | 14,000,000 | 8,000,000 | 5,000,000 | 22,000,000 | 6,000,000 | 17,000,000 | 11,000,000 | 9,000,000 | 6,000,000 | 10,000,000 | 8,000,000 | 11,000,000 | 14,000,000 | 11,000,000 | 10,000,000 | 11,000,000 | 12,000,000 | 12,000,000 | 12,000,000 | ||||||||||||||||||||||||||||||||
current tax liabilities | 23,000,000 | 24,000,000 | 26,000,000 | 25,000,000 | 23,000,000 | 32,000,000 | 32,000,000 | 32,000,000 | 39,000,000 | 49,000,000 | 49,000,000 | 36,000,000 | 40,000,000 | 37,000,000 | 29,000,000 | 23,000,000 | 20,000,000 | 28,000,000 | 19,000,000 | 19,000,000 | 18,000,000 | |||||||||||||||||||||||||||||||||||||||||||
long-term borrowings, excluding current portion | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
long-term borrowings, current | 1,000,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
long-term borrowings, excluding current | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
particulars | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
provisions – non-current | 1,000,000 | 1,000,000 | 1,000,000 | 1,000,000 | 1,000,000 | 1,000,000 | 1,000,000 | 1,000,000 | 1,000,000 | 1,000,000 | 1,000,000 | 1,000,000 | 1,000,000 | 2,000,000 | 1,000,000 | 1,000,000 | 1,000,000 | 1,000,000 | ||||||||||||||||||||||||||||||||||||||||||||||
trade and other receivables – non-current | 3,000,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
other investments – non-current | 81,000,000 | 86,000,000 | 74,000,000 | 29,000,000 | 30,000,000 | 52,000,000 | 37,000,000 | 60,000,000 | 45,000,000 | 4,000,000 | 9,000,000 | 4,000,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||
equity shares held by controlled trust | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
long-term loans and borrowings, excluding current portion | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
equity attributable to equity holders of the company | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
trade receivables | 562,000,000 | 532,000,000 | 490,000,000 | 586,000,000 | 490,000,000 | 496,000,000 | 449,000,000 | 498,000,000 | 419,000,000 | 384,000,000 | 395,000,000 | 315,000,000 | 300,000,000 | 275,000,000 | 266,000,000 | |||||||||||||||||||||||||||||||||||||||||||||||||
investment in equity accounted investee | 13,000,000 | 12,000,000 | 11,000,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
other investment – non-current | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
trade payables | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
non-controlling interest | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
intangible assets | 189,000,000 | 192,000,000 | 199,000,000 | 189,000,000 | 194,000,000 | 2,867,567,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
equity attributable to owners of the parent | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
equity holders of the company | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
deferred income tax assets | 67,000,000 | 54,000,000 | 49,000,000 | 39,000,000 | 74,000,000 | 75,000,000 | 43,000,000 | 46,000,000 | 36,000,000 | 34,000,000 | 29,000,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||
current income tax liabilities | 22,000,000 | 24,000,000 | 17,000,000 | 13,000,000 | 38,000,000 | 48,000,000 | 28,000,000 | 35,000,000 | 40,000,000 | 34,000,000 | 32,000,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||
other liabilities | 19,000,000 | 19,000,000 | 19,000,000 | 21,000,000 | 16,000,000 | 16,000,000 | 15,000,000 | 10,000,000 | 9,000,000 | 9,000,000 | 6,000,000 | 126,849,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||
equity shares held by a controlled trust | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
total equity attributable to: | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
other investments—non-current | 4,000,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
current assets: | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
restricted cash | 26,709,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
accounts receivable | 3,620,020,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
deferred income taxes | 166,510,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
due from related parties | 22,863,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
investment securities | 8,715,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
investment in affiliates | 170,184,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
other assets | 43,791,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
liabilities and stockholders’ equity | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
current liabilities: | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
long-term debt, excluding current portion | 40,909,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
deferred revenue | 288,382,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
stockholders’ equity: | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
equity shares at rs.5 par value; 100,000,000 shares authorized; issued and outstanding; 76,515,948 shares as of march 31, 2002 and 2003, respectively | 382,580,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
additional paid-in capital | 10,085,004,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
equity shares held by a controlled trust: 41,400 shares | -4,882,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
accumulated other comprehensive income | 46,328,000 |
Cashflow Statements:
Quarterly
Annual
| Unit: USD | 2025-10-24 | 2025-07-23 | 2025-01-23 | 2024-11-05 | 2024-07-27 | 2024-01-30 | 2023-10-27 | 2023-07-28 | 2023-07-26 | 2023-01-25 | 2022-09-30 | 2022-07-29 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-11-05 | 2021-09-30 | 2021-07-27 | 2021-03-31 | 2021-02-02 | 2020-10-29 | 2020-07-29 | 2020-03-31 | 2020-01-31 | 2019-11-01 | 2019-07-29 | 2019-03-31 | 2018-12-31 | 2018-09-30 | 2018-06-30 | 2018-03-31 | 2017-12-31 | 2017-09-30 | 2017-06-30 | 2017-03-31 | 2016-12-31 | 2016-09-30 | 2016-06-30 | 2016-03-31 | 2015-12-31 | 2015-09-30 | 2015-06-30 | 2015-03-31 | 2014-12-31 | 2014-09-30 | 2014-06-30 | 2014-03-31 | 2013-12-31 | 2013-03-31 | 2012-12-31 | 2012-09-30 | 2012-06-30 | 2012-03-31 | 2011-12-31 | 2011-09-30 | 2011-06-30 | 2011-03-31 | 2010-12-31 | 2010-09-30 | 2010-06-30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
cash flows from operating activities: | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
profit for the period | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
adjustments for: | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
tax expense | 44,000,000 | 58,000,000 | 53,000,000 | 68,000,000 | 59,000,000 | 53,000,000 | 52,000,000 | 54,000,000 | 54,000,000 | 46,000,000 | 60,000,000 | 35,000,000 | 35,000,000 | 19,000,000 | 36,000,000 | 0 | 60,000,000 | 23,000,000 | ||||||||||||||||||||||||||||||||||||||||||
fair value changes and profit on sale of financial instruments measured at fvtpl | -6,000,000 | -8,000,000 | -6,000,000 | -10,000,000 | -9,000,000 | -9,000,000 | -9,000,000 | -3,000,000 | 0 | -1,000,000 | -1,000,000 | -1,000,000 | 0 | |||||||||||||||||||||||||||||||||||||||||||||||
depreciation and amortization | 55,000,000 | 56,000,000 | 53,000,000 | 47,000,000 | 46,000,000 | 45,000,000 | 46,000,000 | 43,000,000 | 43,000,000 | 38,000,000 | 37,000,000 | 39,000,000 | 39,000,000 | 37,000,000 | 40,000,000 | 39,000,000 | 43,000,000 | 45,000,000 | 45,000,000 | 42,000,000 | 32,000,000 | 42,000,000 | 46,000,000 | 45,000,000 | 45,000,000 | 49,000,000 | 38,000,000 | 44,000,000 | 44,000,000 | 48,000,000 | 45,000,000 | 43,000,000 | 50,000,000 | 41,000,000 | 43,000,000 | 40,000,000 | 45,000,000 | 38,000,000 | 36,000,000 | 36,000,000 | 37,000,000 | 31,000,000 | 31,000,000 | 31,000,000 | 35,000,000 | 30,000,000 | 28,000,000 | 23,000,000 | 28,000,000 | 23,000,000 | 30,000,000 | 21,000,000 | 23,000,000 | 28,000,000 | 24,000,000 | 24,000,000 | 24,000,000 | 21,000,000 | ||
impairment of non-current assets | 0 | 10,000,000 | 1,000,000 | 1,000,000 | 99,000,000 | 25,000,000 | 81,000,000 | -13,000,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||
allowance for credit losses | 5,000,000 | 3,000,000 | 0 | 1,000,000 | 0 | 0 | 1,000,000 | 1,000,000 | -1,000,000 | 0 | 1,000,000 | 1,000,000 | 1,000,000 | 0 | 1,000,000 | |||||||||||||||||||||||||||||||||||||||||||||
gain on sale or de-recognition of non-current assets | 0 | -4,000,000 | -1,000,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
share of profit of equity accounted investees | -1,000,000 | 0 | -1,000,000 | 0 | -1,000,000 | -1,000,000 | -1,000,000 | -2,000,000 | -1,000,000 | -1,000,000 | -1,000,000 | -2,000,000 | -2,000,000 | -3,000,000 | -2,000,000 | -1,000,000 | -1,000,000 | -1,000,000 | -2,000,000 | -2,000,000 | -2,000,000 | -2,000,000 | -1,000,000 | -1,000,000 | -1,000,000 | -1,000,000 | -2,000,000 | -1,000,000 | -1,000,000 | |||||||||||||||||||||||||||||||
inventories write-down | 20,000,000 | 19,000,000 | 16,000,000 | 18,000,000 | 16,000,000 | 12,000,000 | 6,000,000 | 11,000,000 | 11,000,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||
unrealized exchange gain | -20,000,000 | 14,000,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
interest expense | 0 | -3,000,000 | -2,000,000 | -2,000,000 | -5,000,000 | 1,000,000 | 1,000,000 | 1,000,000 | 1,000,000 | 2,000,000 | 2,000,000 | -1,000,000 | 0 | 0 | 0 | 1,000,000 | 1,000,000 | 0 | 2,000,000 | -2,000,000 | 3,000,000 | 1,000,000 | -2,000,000 | 0 | 1,000,000 | 1,000,000 | 1,000,000 | 1,000,000 | 0 | 0 | 1,000,000 | 3,000,000 | 2,000,000 | 4,000,000 | 5,000,000 | 2,000,000 | ||||||||||||||||||||||||
equity settled share-based payment expense | 1,000,000 | 1,000,000 | 2,000,000 | 1,000,000 | 1,000,000 | 1,000,000 | 1,000,000 | 2,000,000 | 2,000,000 | 2,000,000 | 1,000,000 | 2,000,000 | 2,000,000 | 2,000,000 | 2,000,000 | 2,000,000 | 2,000,000 | 2,000,000 | 2,000,000 | 2,000,000 | 1,000,000 | 2,000,000 | 2,000,000 | 2,000,000 | 2,000,000 | 2,000,000 | 1,000,000 | 1,000,000 | ||||||||||||||||||||||||||||||||
changes in operating assets and liabilities: | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
trade and other receivables | -31,000,000 | -56,000,000 | -91,000,000 | -41,000,000 | -9,000,000 | -106,000,000 | 89,000,000 | -57,000,000 | -57,000,000 | 25,000,000 | -44,000,000 | -81,000,000 | -81,000,000 | -51,000,000 | 84,000,000 | -154,000,000 | 50,000,000 | -44,000,000 | -26,000,000 | 48,000,000 | -74,000,000 | -55,000,000 | -64,000,000 | 28,000,000 | -35,000,000 | 101,000,000 | 42,000,000 | -21,000,000 | -5,000,000 | -48,000,000 | 27,000,000 | -53,000,000 | -26,000,000 | 99,000,000 | -29,000,000 | -71,000,000 | -32,000,000 | -43,000,000 | ||||||||||||||||||||||
inventories | -21,000,000 | -71,000,000 | -10,000,000 | -59,000,000 | -76,000,000 | -63,000,000 | -55,000,000 | -57,000,000 | -57,000,000 | -4,000,000 | 35,000,000 | -12,000,000 | -12,000,000 | -13,000,000 | 1,000,000 | -72,000,000 | -15,000,000 | -44,000,000 | -28,000,000 | -48,000,000 | 38,000,000 | -37,000,000 | 1,000,000 | -22,000,000 | -14,000,000 | -40,000,000 | -45,000,000 | -7,000,000 | 5,000,000 | -3,000,000 | 0 | -29,000,000 | -24,000,000 | -45,000,000 | 3,000,000 | -5,000,000 | -22,000,000 | -14,000,000 | 34,000,000 | -33,000,000 | -54,000,000 | -34,000,000 | -10,000,000 | -11,000,000 | 16,000,000 | -25,000,000 | -36,000,000 | -26,000,000 | -8,000,000 | -12,000,000 | -29,000,000 | -36,000,000 | -16,000,000 | -19,000,000 | -14,000,000 | -32,000,000 | ||||
trade and other payables | 28,000,000 | 72,000,000 | -16,000,000 | 18,000,000 | 30,000,000 | 5,000,000 | 28,000,000 | 27,000,000 | 27,000,000 | 34,000,000 | -22,000,000 | -7,000,000 | -7,000,000 | 12,000,000 | -21,000,000 | 64,000,000 | -17,000,000 | -9,000,000 | 33,000,000 | 32,000,000 | -21,000,000 | 29,000,000 | 8,000,000 | 5,000,000 | -5,000,000 | 33,000,000 | 15,000,000 | 18,000,000 | 6,000,000 | -1,000,000 | 10,000,000 | 11,000,000 | -4,000,000 | 12,000,000 | 4,000,000 | -17,000,000 | 16,000,000 | 8,000,000 | -19,000,000 | -9,000,000 | 31,000,000 | -2,000,000 | ||||||||||||||||||
other assets and other liabilities | -2,000,000 | -40,000,000 | 9,000,000 | -16,000,000 | -97,000,000 | 22,000,000 | -28,000,000 | -14,000,000 | -14,000,000 | 21,000,000 | -87,000,000 | 17,000,000 | 17,000,000 | 35,000,000 | 27,000,000 | 8,000,000 | 1,000,000 | -15,000,000 | -39,000,000 | 15,000,000 | 37,000,000 | 24,000,000 | -12,000,000 | 19,000,000 | -7,000,000 | -42,000,000 | -7,000,000 | -11,000,000 | -34,000,000 | -22,000,000 | 15,000,000 | 7,000,000 | -61,000,000 | 1,000,000 | 34,000,000 | 2,000,000 | -26,000,000 | 25,000,000 | 15,000,000 | 3,000,000 | 14,000,000 | -27,000,000 | -22,000,000 | -32,000,000 | -7,000,000 | 6,000,000 | ||||||||||||||
cash generated from operations | 232,000,000 | 208,000,000 | 149,000,000 | 191,000,000 | 126,000,000 | 129,000,000 | 287,000,000 | 166,000,000 | 166,000,000 | 306,000,000 | 154,000,000 | 99,000,000 | 99,000,000 | 138,000,000 | 260,000,000 | 184,000,000 | 80,000,000 | 146,000,000 | 156,000,000 | 33,000,000 | 123,000,000 | 176,000,000 | 158,000,000 | |||||||||||||||||||||||||||||||||||||
income tax paid | -63,000,000 | -37,000,000 | -75,000,000 | -87,000,000 | -18,000,000 | -72,000,000 | -73,000,000 | -29,000,000 | -29,000,000 | -28,000,000 | -43,000,000 | -14,000,000 | -14,000,000 | -24,000,000 | -26,000,000 | -16,000,000 | -31,000,000 | -19,000,000 | -16,000,000 | -12,000,000 | -19,000,000 | -23,000,000 | -37,000,000 | -15,000,000 | -28,000,000 | -17,000,000 | -10,000,000 | -15,000,000 | -11,000,000 | -6,000,000 | -33,000,000 | -13,000,000 | -32,000,000 | -11,000,000 | -44,000,000 | -31,000,000 | -16,000,000 | -15,000,000 | -43,000,000 | -14,000,000 | -16,000,000 | -14,000,000 | -56,000,000 | -28,000,000 | -47,000,000 | -26,000,000 | -23,000,000 | -6,000,000 | -43,000,000 | -17,000,000 | -17,000,000 | -12,000,000 | -20,000,000 | -20,000,000 | -14,000,000 | -12,000,000 | ||||
net cash from operating activities | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
capital expenditures | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
free cash flows | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
cash flows from investing activities: | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
purchase of property, plant and equipment | -56,000,000 | -80,000,000 | -81,000,000 | -84,000,000 | -67,000,000 | -24,000,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
proceeds from sale of property, plant and equipment | 1,000,000 | 3,000,000 | 2,000,000 | 6,000,000 | 0 | -1,000,000 | 2,000,000 | 2,000,000 | 2,000,000 | 1,000,000 | 1,000,000 | 0 | 1,000,000 | 0 | 0 | 0 | 1,000,000 | 1,000,000 | 0 | 1,000,000 | 0 | 0 | -1,000,000 | 7,000,000 | 0 | |||||||||||||||||||||||||||||||||||
purchase of other intangible assets | -54,000,000 | -38,000,000 | -19,000,000 | -4,000,000 | -16,000,000 | -3,000,000 | -18,000,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||
proceeds from sale of other intangible assets | 0 | -1,000,000 | 0 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
purchase of other investments | -556,000,000 | -602,000,000 | -595,000,000 | -914,000,000 | -740,000,000 | -421,000,000 | -482,000,000 | -361,000,000 | -361,000,000 | -483,000,000 | -235,000,000 | -343,000,000 | -343,000,000 | -625,000,000 | -142,000,000 | -249,000,000 | -225,000,000 | -113,000,000 | -243,000,000 | -450,000,000 | -184,000,000 | -320,000,000 | -264,000,000 | -717,000,000 | -240,000,000 | -391,000,000 | -410,000,000 | -264,000,000 | -295,000,000 | -82,000,000 | -235,000,000 | -111,000,000 | -224,000,000 | -196,000,000 | -450,000,000 | -184,000,000 | -145,000,000 | -251,000,000 | -440,000,000 | -154,000,000 | -117,000,000 | -147,000,000 | -93,000,000 | |||||||||||||||||
proceeds from sale of other investments | 564,000,000 | 487,000,000 | 615,000,000 | 1,381,000,000 | 567,000,000 | 278,000,000 | 460,000,000 | 404,000,000 | 404,000,000 | 196,000,000 | 342,000,000 | 388,000,000 | 388,000,000 | 385,000,000 | 161,000,000 | 215,000,000 | 136,000,000 | 226,000,000 | 266,000,000 | 459,000,000 | 100,000,000 | 449,000,000 | 257,000,000 | 676,000,000 | 257,000,000 | 293,000,000 | 252,000,000 | 301,000,000 | 447,000,000 | 155,000,000 | 258,000,000 | 124,000,000 | 250,000,000 | 181,000,000 | 237,000,000 | 436,000,000 | 415,000,000 | 115,000,000 | 172,000,000 | 344,000,000 | 252,000,000 | 128,000,000 | 217,000,000 | 128,000,000 | 52,000,000 | |||||||||||||||
investment in associates | 0 | -1,000,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
payment for acquisition of businesses | 13,000,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
interest and dividend received | -1,000,000 | 10,000,000 | 12,000,000 | 10,000,000 | 5,000,000 | 4,000,000 | 2,000,000 | 5,000,000 | 2,000,000 | 3,000,000 | 1,000,000 | 1,000,000 | 2,000,000 | 2,000,000 | 1,000,000 | 3,000,000 | 0 | 1,000,000 | 6,000,000 | 11,000,000 | 4,000,000 | 1,000,000 | 3,000,000 | 1,000,000 | 5,000,000 | |||||||||||||||||||||||||||||||||||
net cash from investing activities | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
cash flows from financing activities: | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
proceeds from issuance of equity shares in subsidiary comprising nci | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
proceeds from issuance of equity shares | 1,000,000 | 2,000,000 | 0 | 1,000,000 | 1,000,000 | 0 | 8,000,000 | 1,000,000 | 1,000,000 | 1,000,000 | 0 | 2,000,000 | 1,000,000 | 1,000,000 | 1,000,000 | 0 | 0 | 0 | 1,000,000 | |||||||||||||||||||||||||||||||||||||||||
proceeds from short-term borrowings | 29,000,000 | 1,000,000 | 36,000,000 | 74,000,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
payment of principal portion of lease liabilities | -3,000,000 | -4,000,000 | -3,000,000 | -5,000,000 | -4,000,000 | -5,000,000 | -2,000,000 | -4,000,000 | -4,000,000 | -2,000,000 | -2,000,000 | -4,000,000 | -4,000,000 | -2,000,000 | -2,000,000 | -3,000,000 | -2,000,000 | -3,000,000 | -3,000,000 | -2,000,000 | ||||||||||||||||||||||||||||||||||||||||
dividend paid | 2,000,000 | 0 | 1,000,000 | 1,000,000 | 0 | 0 | -1,000,000 | 0 | -3,000,000 | 2,000,000 | -2,000,000 | -2,000,000 | 1,000,000 | 0 | 1,000,000 | -1,000,000 | 1,000,000 | -2,000,000 | 0 | -1,000,000 | 2,000,000 | -2,000,000 | 3,000,000 | -19,000,000 | 0 | |||||||||||||||||||||||||||||||||||
interest paid | -13,000,000 | -13,000,000 | -11,000,000 | -11,000,000 | -9,000,000 | -6,000,000 | -6,000,000 | -7,000,000 | -7,000,000 | -7,000,000 | -4,000,000 | -7,000,000 | -7,000,000 | -4,000,000 | -6,000,000 | -5,000,000 | -4,000,000 | -6,000,000 | -4,000,000 | -4,000,000 | -3,000,000 | -6,000,000 | -6,000,000 | -6,000,000 | -6,000,000 | -7,000,000 | -5,000,000 | -5,000,000 | -5,000,000 | -5,000,000 | -3,000,000 | -4,000,000 | -5,000,000 | -13,000,000 | -2,000,000 | -5,000,000 | -3,000,000 | -13,000,000 | -3,000,000 | -3,000,000 | -3,000,000 | -2,000,000 | -3,000,000 | -2,000,000 | -1,000,000 | |||||||||||||||
net cash from financing activities | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
net increase in cash and cash equivalents | 19,000,000 | 77,000,000 | -27,000,000 | -74,000,000 | 161,000,000 | -91,000,000 | 6,000,000 | 56,000,000 | -31,000,000 | 8,000,000 | -28,000,000 | 9,000,000 | -8,000,000 | -7,000,000 | -14,000,000 | -32,000,000 | 57,000,000 | -57,000,000 | 22,000,000 | 45,000,000 | -5,000,000 | 5,000,000 | 13,000,000 | -32,000,000 | -63,000,000 | 28,000,000 | -24,000,000 | 15,000,000 | -171,000,000 | 167,000,000 | 36,000,000 | -8,000,000 | 33,000,000 | -53,000,000 | 3,000,000 | -6,000,000 | ||||||||||||||||||||||||
effect of exchange rate changes on cash and cash equivalents | 2,000,000 | 2,000,000 | 1,000,000 | -1,000,000 | -1,000,000 | -1,000,000 | -3,000,000 | 2,000,000 | 6,000,000 | 6,000,000 | 9,000,000 | 0 | 2,000,000 | 1,000,000 | 1,000,000 | 0 | -1,000,000 | -1,000,000 | 0 | 2,000,000 | -14,000,000 | -5,000,000 | -1,000,000 | -5,000,000 | 5,000,000 | -2,000,000 | 4,000,000 | -2,000,000 | 5,000,000 | 4,000,000 | 3,000,000 | 1,000,000 | 7,000,000 | -6,000,000 | 1,000,000 | |||||||||||||||||||||||||
cash and cash equivalents at the beginning of the period* | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
cash and cash equivalents at the end of the period (refer to note 4 for details)** | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
net decrease in cash and cash equivalents | -67,000,000 | 19,000,000 | 19,000,000 | 36,000,000 | -115,000,000 | -115,000,000 | -2,000,000 | -2,000,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||
cash and cash equivalents at the beginning of the period** | 170,000,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
cash and cash equivalents at the end of the period | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
investments in associates | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
dividend received from equity accounted investees | 0 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
proceeds from issuance of equity shares in subsidiary to nci | -2,000,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
proceeds from/(repayment of) short-term borrowings | 14,000,000 | 22,000,000 | 23,000,000 | 35,000,000 | 39,000,000 | -268,000,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
repayment of long term borrowings | 0 | -3,000,000 | -1,000,000 | 2,000,000 | -138,000,000 | -40,000,000 | -31,000,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||
proceeds from long term borrowings | 0 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
cash and cash equivalents at the beginning of the period | -2,000,000 | 0 | 85,000,000 | -1,000,000 | 0 | 70,000,000 | 70,000,000 | -3,000,000 | -5,000,000 | 188,000,000 | 188,000,000 | -1,000,000 | 199,000,000 | 0 | 1,000,000 | 26,000,000 | -1,000,000 | 0 | 32,000,000 | 2,000,000 | -2,000,000 | 37,000,000 | 1,000,000 | 0 | 58,000,000 | -2,000,000 | 1,000,000 | 73,000,000 | 0 | -1,000,000 | -3,000,000 | 85,000,000 | 2,000,000 | -2,000,000 | -5,000,000 | 141,000,000 | 2,000,000 | 1,000,000 | 0 | -4,000,000 | 6,000,000 | 133,000,000 | 4,000,000 | -8,000,000 | -12,000,000 | 127,000,000 | 1,000,000 | -1,000,000 | 6,000,000 | 141,000,000 | ||||||||||
unrealized exchange loss | 3,000,000 | 3,000,000 | 0 | 3,000,000 | -1,000,000 | -4,000,000 | 18,000,000 | 30,000,000 | -8,000,000 | -17,000,000 | -8,000,000 | -14,000,000 | 0 | -2,000,000 | ||||||||||||||||||||||||||||||||||||||||||||||
interest income | 1,000,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
fair value changes and profit on sale of financial instruments measured at fvtpl** | -11,000,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
cash flows from/(used in) in financing activities: | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
proceeds from/(repayments of) short-term borrowings | 127,000,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
proceeds from long-term borrowings | 46,000,000 | 46,000,000 | 0 | 0 | 27,000,000 | 25,000,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
repayment of long-term borrowings | -46,000,000 | -46,000,000 | 0 | 0 | -26,000,000 | -25,000,000 | -201,000,000 | 0 | -100,000,000 | 0 | ||||||||||||||||||||||||||||||||||||||||||||||||||
loss on sale or de-recognition of non-current assets | -6,000,000 | 0 | 1,000,000 | 0 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
share of profit of equity accounted investees, net of tax | 6,000,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
foreign exchange gain | 9,000,000 | -7,000,000 | -7,000,000 | -7,000,000 | -2,000,000 | 41,000,000 | -45,000,000 | -45,000,000 | -32,000,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||
dividend income | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
expenditures on property, plant and equipment | -46,000,000 | -44,000,000 | -44,000,000 | -44,000,000 | -35,000,000 | -29,000,000 | -42,000,000 | -42,000,000 | -56,000,000 | -43,000,000 | -25,000,000 | -22,000,000 | -32,000,000 | -41,000,000 | -54,000,000 | -61,000,000 | -48,000,000 | -41,000,000 | ||||||||||||||||||||||||||||||||||||||||||
expenditures on other intangible assets | -14,000,000 | -2,000,000 | -104,000,000 | -104,000,000 | -1,000,000 | -8,000,000 | -68,000,000 | -68,000,000 | -3,000,000 | -4,000,000 | -2,000,000 | -5,000,000 | ||||||||||||||||||||||||||||||||||||||||||||||||
proceeds/(repayment) of short-term borrowings | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
cash flows (used in) /from investing activities: | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
net cash (used in) / from investing activities | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
repayment of short-term borrowings | 19,000,000 | -20,000,000 | -139,000,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
interest received | 4,000,000 | 4,000,000 | 1,000,000 | 1,000,000 | 3,000,000 | 3,000,000 | 5,000,000 | 3,000,000 | 7,000,000 | 4,000,000 | 3,000,000 | 3,000,000 | 10,000,000 | 1,000,000 | 11,000,000 | 1,000,000 | 3,000,000 | 1,000,000 | 6,000,000 | 0 | 1,000,000 | |||||||||||||||||||||||||||||||||||||||
repayment of from short-term borrowings | -8,000,000 | -8,000,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
cash flows (used in)/from financing activities: | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(repayment of)/proceeds from short-term borrowings | -127,000,000 | -127,000,000 | -27,000,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
net cash (used in)/from financing activities | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
particulars | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
profit for the year | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
foreign exchange loss | -6,000,000 | 1,000,000 | -6,000,000 | 9,000,000 | 4,000,000 | 8,000,000 | -6,000,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||
payment for acquisition of business | 0 | -1,000,000 | -13,000,000 | -198,000,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
dividends received from equity accounted investees | 0 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
purchase of treasury shares | -13,000,000 | 0 | 1,000,000 | 0 | 0 | -7,000,000 | -1,000,000 | -6,000,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||
net (decrease)/increase in cash and cash equivalents | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
cash and cash equivalents at the beginning of the year | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
cash and cash equivalents at the end of the year | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
revenues | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
cost of revenues | 679,000,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
gross profit | 762,000,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
selling, general and administrative expenses | 418,000,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
research and development expenses | 121,000,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
other income | -30,000,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
total operating expenses | 509,000,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
results from operating activities | 252,000,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
finance income | 19,000,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
finance expense | -6,000,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
profit before tax [(a)+(b)+(c)] | 271,000,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
earnings per share: | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
basic earnings per share of rs.5/- each | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
diluted earnings per share of rs.5/- each | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
6 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
cash flows (used in)/from operating activities: | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
fair value changes and profit on sale of units of mutual funds | -2,000,000 | -1,000,000 | -2,000,000 | -2,000,000 | -3,000,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
cash (used in)/generated from operations | -30,000,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
net cash (used in)/from operating activities | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
tax expense/(benefit) | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
loss/(gain) on sale or de-recognition of non-current assets | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
foreign exchange loss/(gain) | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
cash flows used in investing activities: | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
cash flows used in financing activities: | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
proceeds from/ | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
net increase/(decrease) in cash and cash equivalents | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
cash flows (used in)/from investing activities: | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
expenditure on property, plant and equipment | -40,000,000 | -34,000,000 | -20,000,000 | -17,000,000 | -15,000,000 | -15,000,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
expenditure on other intangible assets | -26,000,000 | -3,000,000 | -5,000,000 | -2,000,000 | -1,000,000 | -6,000,000 | 6,000,000 | -355,000,000 | -68,000,000 | -4,000,000 | -25,000,000 | -5,000,000 | -3,000,000 | -1,000,000 | ||||||||||||||||||||||||||||||||||||||||||||||
net cash (used in)/from investing activities | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
income tax expense | 14,000,000 | 40,000,000 | -5,000,000 | 6,000,000 | -47,000,000 | 27,000,000 | 22,000,000 | 15,000,000 | 9,000,000 | 7,000,000 | 10,000,000 | 42,000,000 | 15,000,000 | 3,000,000 | 2,000,000 | 18,000,000 | 13,000,000 | 7,000,000 | 27,000,000 | 26,000,000 | 28,000,000 | 27,000,000 | 13,000,000 | 39,000,000 | 19,000,000 | 25,000,000 | 23,000,000 | 41,000,000 | 40,000,000 | 15,000,000 | 28,000,000 | 7,000,000 | 19,000,000 | 49,000,000 | 12,000,000 | 3,000,000 | 12,000,000 | 4,000,000 | 7,000,000 | 8,000,000 | ||||||||||||||||||||
fair value changes and profit on sale of mutual funds | -1,000,000 | -3,000,000 | -3,000,000 | -5,000,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
loss on sale or de-recognition of property, plant and equipment and other intangible assets | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
dividends income | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
cash generated from operating activities: | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
allowance for credit loss and doubtful trade receivables and other advances | 1,000,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
gain on sale or de-recognition of property, plant and equipment and other intangible assets | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
net cash generated from operating activities | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
proceeds from sale of property, plant and equipment, and other intangible assets | 1,000,000 | 13,000,000 | 12,000,000 | 5,000,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
interest and dividends received | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
net cash generated from investing activities | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
dividends paid | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
impairment loss on property, plant and equipment, goodwill and other intangible assets | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
cash from operating activities: | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
impairment loss on property, plant and equipment, and other intangible assets | 0 | 0 | 2,000,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
allowance for credit loss and doubtful trade and other advances | 1,000,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
loss on sale of property, plant and equipment and other intangible assets | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
proceeds from sale of property, plant and equipment and other intangible assets | 5,000,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
net cash generated from financing activities | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
dividend and profit on sale of investments | -17,000,000 | -12,000,000 | -2,000,000 | -4,000,000 | -4,000,000 | -1,000,000 | -5,000,000 | -1,000,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||
impairment loss on property, plant and equipment and other intangible assets | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
inventory write-downs | 17,000,000 | 19,000,000 | 10,000,000 | 12,000,000 | 12,000,000 | 9,000,000 | 13,000,000 | 11,000,000 | 19,000,000 | 7,000,000 | 12,000,000 | 10,000,000 | 14,000,000 | 12,000,000 | 7,000,000 | 8,000,000 | 18,000,000 | 19,000,000 | 9,000,000 | 12,000,000 | 12,000,000 | 6,000,000 | 13,000,000 | 6,000,000 | 8,000,000 | 8,000,000 | 10,000,000 | 4,000,000 | 8,000,000 | 7,000,000 | 7,000,000 | 8,000,000 | 8,000,000 | 5,000,000 | ||||||||||||||||||||||||||
allowance for credit losses on trade receivables and other advances | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
loss on sale/disposal of property, plant and equipment and other intangible assets | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
refund liability | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
investment in equity accounted investees | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
cash paid for acquisition of business, net of cash acquired | 0 | 1,000,000 | 4,000,000 | -125,000,000 | 0 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
buyback of equity shares | -11,000,000 | 5,000,000 | -4,000,000 | -232,000,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
realized and unrealized gains on investments | -4,000,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
allowance for credit loss and doubtful trade and other receivables | -1,000,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(profit)/loss on sale of property, plant and equipment and other intangible assets | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
allowance for sales returns | 15,000,000 | 12,000,000 | 10,000,000 | 8,000,000 | 12,000,000 | 8,000,000 | 13,000,000 | 16,000,000 | 15,000,000 | 11,000,000 | 7,000,000 | 17,000,000 | 11,000,000 | 11,000,000 | 10,000,000 | 23,000,000 | 12,000,000 | 14,000,000 | 8,000,000 | 16,000,000 | 9,000,000 | 17,000,000 | 6,000,000 | 6,000,000 | 4,000,000 | 7,000,000 | 4,000,000 | 4,000,000 | 6,000,000 | |||||||||||||||||||||||||||||||
exchange gain | 8,000,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
profit on sale of property, plant and equipment and other intangible assets | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
net cash used in financing activities | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
loss/(profit) on sale of property, plant and equipment and other intangible assets | 1,000,000 | 0 | 0 | 1,000,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
cash from operations | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
acquisition of other intangible assets | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
allowance for doubtful trade and other receivables | 0 | 1,000,000 | 0 | 0 | 1,000,000 | 1,000,000 | -1,000,000 | 1,000,000 | 1,000,000 | 1,000,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||
exchange loss | 19,000,000 | -1,000,000 | -7,000,000 | -16,000,000 | 8,000,000 | -2,000,000 | -2,000,000 | 5,000,000 | -16,000,000 | 18,000,000 | 6,000,000 | 8,000,000 | 20,000,000 | 3,000,000 | 0 | 1,000,000 | ||||||||||||||||||||||||||||||||||||||||||||
exchange loss related to venezuela operations | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
proceeds from/(repayment of) short term borrowings | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
proceeds from/(repayment of) long term borrowings | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
supplemental schedule of non-cash investing and financing activities: | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
investment in shares of curis, inc. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
acquisition of select products portfolio of ucb | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
property, plant and equipment and intangibles purchased on credit during the year, including contingent consideration on purchase of intangibles | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
property, plant and equipment purchased under capital lease | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
impairment on other intangible assets | 0 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
share based payment expense | 2,000,000 | 1,000,000 | 2,000,000 | 2,000,000 | 2,000,000 | 1,000,000 | 1,000,000 | 2,000,000 | 1,000,000 | 2,000,000 | 2,000,000 | 2,000,000 | 2,000,000 | 2,000,000 | 2,000,000 | 2,000,000 | 2,000,000 | 2,000,000 | 2,000,000 | 2,000,000 | 1,000,000 | 2,000,000 | 1,000,000 | 2,000,000 | 1,000,000 | 2,000,000 | 1,000,000 | 2,000,000 | 1,000,000 | |||||||||||||||||||||||||||||||
cash flows from operating activities | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
proceeds from/(repayment of) long-term borrowings | 6,000,000 | -2,000,000 | 293,000,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
cash generated/(used in) operations | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
proceeds from sale of equity shares held by a controlled trust | 0 | 0 | 0 | 3,000,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
proceeds from/(repayment of) of short term borrowings | 19,000,000 | 349,000,000 | 52,000,000 | -14,000,000 | -47,000,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
impairment loss/(reversal of impairment loss) on property, plant and equipment and other intangible assets | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
redemption of bonus debentures | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
cash paid for acquisition of non-controlling interests | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
impairment loss on intangible asset | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
impairment loss/(reversal of impairment loss) on other intangible assets | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
impairment loss on goodwill | 0 | 0 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
impairment loss/(reversal of impairment loss) on intangible asset | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
repayment of short term borrowings | 60,000,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
profit on sale of investments | -1,000,000 | 0 | 0 | -1,000,000 | 0 | 0 | -1,000,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||
allowance/(reversal of allowance) for doubtful trade and other receivables | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
proceeds from/(repayment of) short term loans and borrowings | -54,000,000 | 32,000,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
repayment of long term loans and borrowings | -1,000,000 | -159,000,000 | -22,000,000 | -19,000,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
adjustment for: | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
proceeds from long term loans and borrowings | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
repayment of other long term loans and borrowings | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
impairment loss/(reversal of impairment loss) on intangible assets | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
allowance for doubtful trade receivables | 3,000,000 | 0 | 1,000,000 | 0 | 1,000,000 | 2,000,000 | 0 | 2,000,000 | 0 | |||||||||||||||||||||||||||||||||||||||||||||||||||
(profit)/loss on sale of property, plant and equipment and intangible assets | 0 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
share of profit of equity accounted investees, net of income tax | -1,000,000 | 0 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
trade receivables | -35,000,000 | -107,000,000 | 8,000,000 | -38,000,000 | 21,000,000 | -6,000,000 | -121,000,000 | -40,000,000 | 31,000,000 | -68,000,000 | -13,000,000 | -20,000,000 | -2,000,000 | |||||||||||||||||||||||||||||||||||||||||||||||
trade payables | -25,000,000 | 12,000,000 | 6,000,000 | 31,000,000 | -15,000,000 | 6,000,000 | 31,000,000 | -13,000,000 | -5,000,000 | 15,000,000 | 10,000,000 | 2,000,000 | -1,000,000 | |||||||||||||||||||||||||||||||||||||||||||||||
purchase of investments | -54,000,000 | -58,000,000 | -31,000,000 | -110,000,000 | -34,000,000 | -39,000,000 | -100,000,000 | -90,000,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||
proceeds from sale of investments | 151,000,000 | 46,000,000 | 33,000,000 | 76,000,000 | 33,000,000 | 32,000,000 | 154,000,000 | 118,000,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||
proceeds from sale of intangible assets | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
expenditures on intangible assets | -4,000,000 | -2,000,000 | 2,000,000 | 2,000,000 | -36,000,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
proceeds from/(repayment of) long term loans and borrowings | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
cash paid for acquisition of non-controlling interest | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
impairment loss on intangible assets | 0 | -1,000,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
proceeds/(repayment) from short term loans and borrowings | 22,000,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
proceeds/(repayment) of long term loans and borrowings | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
loss/(profit) on sale of property, plant and equipment and intangible assets | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
negative goodwill on acquisition of business | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
expenditure on intangible assets | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
proceeds/(repayment) from long term loans and borrowings | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
transfers into escrow account for issuance of bonus debentures | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
proceeds from issuance of bonus debentures | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
costs of issuance of bonus debentures | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
cash flows from/(used) in financing activities: | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
proceeds/(repayment) of short term loans and borrowings | 7,000,000 | -110,000,000 | 127,000,000 | 8,000,000 | 144,000,000 | 26,000,000 | 8,000,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||
net cash from/(used) in financing activities | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
provision for sales returns | 7,000,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
impairment loss on other intangible assets | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
acquisition of non-controlling interest | 0 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
other assets | 35,000,000 | 25,000,000 | 6,000,000 | 22,000,000 | -17,000,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
other liabilities and provisions | -18,000,000 | -30,000,000 | 9,000,000 | 35,000,000 | -36,000,000 | -1,000,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
cash flows from/ (used) in financing activities: | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
net cash from/ (used) in financing activities | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
loss/(profit) on sale of property, plant and equipment | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
payment of contingent consideration for acquisition of business | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
cash paid for acquisition of equity accounted investee, net of cash acquired | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
proceeds from short term loans and borrowings | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
loss on sale of property, plant and equipment | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(profit)/loss on sale of property, plant and equipment | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
other data: | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
net cash from / | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
operating activities | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
investing activities | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
financing activities | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
effect of exchange rate changes on cash | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
balance sheet data: | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
cash and cash equivalents | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
working capital | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
total assets | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
total long-term debt, excluding current portion | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
net assets | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
total stockholders’ equity | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
net income | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
adjustments to reconcile net income to net cash from operating activities: | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
net cash provided by/(used in) financing activities | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
net increase / (decrease) in cash and cash equivalents during the year | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
supplemental disclosures: | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
cash paid for: |